Lumisight

Active Ingredient(s): Pegulicianine
FDA Approved: * April 17, 2024
Pharm Company: * LUMICELL
Category: Diagnostic Aid
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Lumisight 10 mg/ml Intravenous Injection, Powder, Lyophilized, for Solution
NDC: 82292-040
Labeler:
Lumicell, Inc.